RecruitingNot Applicable

Lifestyle Intervention of Food and Exercise for Lymphoma Survivors

United States140 participantsStarted 2023-04-26

Plain-language summary

The purpose of this study is to investigate if a mediterranean diet and exercise program for Lymphoma patients during chemotherapy can improve treatment completion and reduce treatment-related side effects.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. 18 years of age or older
✓. Any sex/gender
✓. Able to provide consent
✓. Able to read or understand English or Spanish
✓. Diagnosis of untreated Non-Hodgkin or Hodgkin lymphoma, requiring at least 6 cycles of chemotherapy, being treated with one of the following therapies at discretion of PIs:
✓. R-CHOP or R-CHOP-like regimen
✓. BR
✓. BV-AVD or ABVD or checkpoint inhibitor+AVD

Exclusion criteria

✕. Individuals younger than 18 years of age
✕. Unable to provide consent
✕. Unable to read or understand English or Spanish
✕. Any contraindication for diet change or exercising as determined by physician
✕. Currently following a vegan or ketogenic diet, or consuming more than 5 servings of fruit and vegetables per day for the prior month
✕. Engaging in \>150 minutes of moderate to vigorous physical activity on average per week for the prior month
✕. History of dementia or major psychiatric disease
✕. History of recent (≤1 yr) stroke, myocardial infarction or congestive heart failure

What they're measuring

Percentage of Survivors who participate

Timeframe: Up to 12 months

Percentage of Participants Completing Intervention Sessions

Timeframe: Up to 26 weeks (Post-Intervention)

Change in percentage of participant satisfaction

Timeframe: 4 weeks (post-intervention), up to 30 weeks

Trial details

NCT IDNCT05839210

SponsorUniversity of Miami

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-10-31

Contact for this trial

Tracy E Crane, PhD, RDN

305-243-8255 tecrane@med.miami.edu

View on ClinicalTrials.gov More Non Hodgkin Lymphoma trials